Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: a multicentre, randomised, double-blind, placebo-controlled phase II trial.
Trilaciclib administered prior to E/P/A improved patients' experience of receiving treatment.
»
08/21/20
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer.
Antigen expression patterns showed modest correlations with TIL.
»
11/02/20
Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in patients with newly diagnosed prostate cancer referred to androgen-deprivation therapy.
PCPs performed poorer than HCs on 7 of 15 neuropsychological tests.
»
09/10/20
Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
Diagnosis of IBD did not significantly impact long-term mortality.
»
11/20/20
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
Worst prognosis observed for patients with triple-negative MBC.
»
04/05/20
Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy.
Providers significantly more likely to not provide routine counseling to female patients.
»
10/25/19
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.
For mobility preservation, one 10-Gy fraction non-inferior to 20 Gy in five fractions.
»
01/22/19
Cervical cancer in women under 25 years of age and outside the screening age: Diagnosis profile and long-term outcomes.
Rate of CC diagnosed women under 25 years 1.5%.
»
12/20/20
Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Results similar for associations with post-diagnosis use of H2 RAs.
»
08/08/19
Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy.
Co‑treatment of W922 and chloroquine led to significant population of apoptotic cells.
»
06/17/20
< Prev
Next >